Recilisib
Recilisib (ON 01210) is a radioprotectant, which can activate AKT, PI3K activities in cells[1].
Product Specifications
CAS Number
334969-03-8
Product Name Alternative
ON 01210
UNSPSC
12352005
Target
Akt; PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Recilisib.html
Purity
99.94
Solubility
DMSO : 20 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(O)C1=CC=C(/C=C/S(=O)(CC2=CC=C(Cl)C=C2)=O)C=C1
Molecular Formula
C16H13ClO4S
Molecular Weight
336.79
References & Citations
[1]Kang AD, et al. ON01210.Na (Ex-RAD) mitigates radiation damage through activation of the AKT pathway. PLoS One. 2013;8 (3) :e58355.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
PI3K
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740755-500 1x 500 µL
Human Kappa Light Chain (HP6053 + L1C1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-A723355-2.5G 2.5 g
4-Amino-3-isopropyl-1H-1,2,4-triazol-5(4H)-one
Sign In for Pricing
View Details 
